Among these potential targets, two oncogenes, MYBL2 and RAD54L, which were previously demonstrated to be targets of E2F145–49, were downregulated in both cancer cell lines upon NSUN2 knockdown (Fig. 6g). This evidence concerns the gene MYBL2 and cancer.